Heart protective effects of cardioactive drugs associated with antineoplastic treatment against breast cancer
Authors:
Open Access
- 24 October 2022
- journal article
- review article
- Published by Termedia Sp. z.o.o. in Contemporary Oncology
- Vol. 26 (3) , 174-179
Abstract
The prevalence of breast cancer in women is a fundamental problem in public health worldwide. There is consensual evidence that many chemotherapeutic agents might have harmful effects on the cardiovascular system of patients. The cardiotoxicity of chemotherapeutic drugs might lead to ventricular...Keywords
This publication has 37 references indexed in Scilit:
- Treatment, Behavioral, and Psychosocial Components of Cardiovascular Disease Risk Among Survivors of Childhood and Young Adult CancerJournal of the American Heart Association, 2015
- Hypertension in Patients with CancerArquivos Brasileiros de Cardiologia, 2015
- Trastuzumab Plus Adjuvant Chemotherapy for Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer: Planned Joint Analysis of Overall Survival From NSABP B-31 and NCCTG N9831Journal of Clinical Oncology, 2014
- Early Increases in Multiple Biomarkers Predict Subsequent Cardiotoxicity in Patients With Breast Cancer Treated With Doxorubicin, Taxanes, and TrastuzumabJACC, 2014
- Protective effects of nebivolol against anthracycline-induced cardiomyopathy: A randomized control studyInternational Journal of Cardiology, 2013
- Cancer drugs and the heart: importance and managementEuropean Heart Journal, 2012
- Mechanisms of Anthracycline Cardiac Injury: Can We Identify Strategies for Cardioprotection?Progress in Cardiovascular Diseases, 2010
- Histological types of breast cancer: How special are they?Molecular Oncology, 2010
- Cardiotoxicity of Anticancer Drugs: The Need for Cardio-Oncology and Cardio-Oncological PreventionJNCI: Journal of the National Cancer Institute, 2010
- Cardiovascular Complications of Cancer TherapyJACC, 2009